This contract opportunity is for pharmaceutical companies to enter into discount agreements for the drug Epoetin beta, as part of the Open-House-Biologika process. The participating health insurance funds aim to establish uniform discount contracts without individual negotiations, ensuring no exclus
Contract awarded. Originally published 5 months ago.
This contract involves establishing substance-related discount agreements according to § 130a Abs. 8 SGB V for specific pharmaceuticals for a maximum period of 24 months, starting no earlier than January 1, 2027 (different start dates may apply based on the details provided for the affected lots). T
The contractor will supply calendars and promotional items to Techniker Krankenkasse (TK). All services will be provided in the contractor's name and upon request from TK.
The health insurance funds (whether HEK and/or hkk participate in each lot is determined by the designation of the respective lot) aim to establish discount contracts with all suitable pharmaceutical companies according to § 130a Abs. 8 SGB V for the active ingredients, combinations of active ingred
The health insurance funds (whether HEK and/or hkk participate in each lot is determined by the designation of the respective lot) aim to enter into discount contracts with all suitable pharmaceutical companies according to § 130a Abs. 8 SGB V for the active ingredients, combinations of active ingre
Supply non-clinical consumables including forms, labels, and packaging for pathology and primary care services.
Procurement of RSV immunisation vaccine products for adult populations, scheduled for 2028.
Procurement for meningococcal ACWY vaccine supply in 2027 from qualified manufacturers or distributors.
Procurement opportunity for MMR vaccine supply with anticipated delivery timeline of 2027.
